银牌会员第2
访问量: 2374622   网址: www.cnreagent.com/show1000160    在线留言 
产品搜索
抗体 >> 其他抗体
HLA-DRB5抗体
HLA-DRB5抗体图片
交货期: 1周
索取资料及报价
交货期:1周
产品别名:Anti-HLA-DRB5
Anti-major histocompatibility complex, class II, DR beta 5 Antibody
产品介绍
靶标:

HLA-DRB5


产品别名:

HLA-DRB5*; HLA-DRB5; major histocompatibility complex, class II, DR beta 5; major histocompatibility complex, class II, DR beta 5; major histocompatibility complex, class II, DR beta 5; DR beta-5; HLA class II histocompatibility antigen, DR-5 beta chain; MHC class II antigen DRB5;


背景信息:
HLA-DRB5 belongs to the HLA class II beta chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DRA) and a beta (DRB) chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The beta chain is approximately 26-28 kDa and its gene contains 6 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail. Within the DR molecule the beta chain contains all the polymorphisms specifying the peptide binding specificities. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. DRB1 is expressed at a level five times higher than its paralogues DRB3, DRB4 and DRB5. The presence of DRB5 is linked with allelic variants of DRB1, otherwise it is omitted. There are 4 related pseudogenes: DRB2, DRB6, DRB7, DRB8 and DRB9.

宿主:Rbt
类型:Pab
同种型:IgG  
应用:WB
纯化方式:亲和纯化
偶联物:Unconjugated
性状:液体
存储溶液:参阅说明书
浓度:Batch dependent (Please refer to the vial label for the specific concentration.)
稀释比例: Optimal dilutions/concentrations should be determined by the end user           
储存:经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
注意事项:仅供实验室使用。不适用于人类或动物的任何临床,治疗或诊断用途。不适合动物或人类食用。

相关产品
我要咨询 关闭
  •      
  • 姓名* 
  • 电话* 
  • 单位* 
  • email 
  • 留言内容*
  • 验证码*  
  • 让更多商家关注